Bliss GVS Pharma gains on plan to sell its step-down subsidiary at Kenya

01 Jun 2015 Evaluate

Bliss GVS Pharma is currently trading at Rs 125.00, up by 0.90 points or 0.73% from its previous closing of Rs. 124.10 on the BSE.

The scrip opened at Rs 127.20 and has touched a high and low of Rs 130.00 and Rs 123.80 respectively. So far 44317 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 1 has touched a 52 week high of Rs. 145.70 on 13-Apr-2015 and a 52 week low of Rs. 39.50 on 30-May-2014.

Last one week high and low of the scrip stood at Rs 130.00 and Rs. 117.30 respectively. The current market cap of the company is Rs. 1286.24 crore.

The promoters holding in the company stood at 64.95% while Institutions and Non-Institutions held 4.73% and 30.33% respectively.

Bliss GVS Pharma has received an approval for the sale of step-down subsidiary ‘Surgimed Pharma’ located at Kenya. The board of directors at their meeting held on May 29, 2015 has approved for the same.

Bliss GVS Pharma manufactures wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.

Bliss GVS Pharma Share Price

155.60 1.90 (1.24%)
22-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.25
Dr. Reddys Lab 1220.20
Cipla 1374.60
Zydus Lifesciences 883.85
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×